99 related articles for article (PubMed ID: 7019232)
1. Rapid changes in somatomedin activity during insulin-induced hypoglycemia: possible release of an inhibitory factor.
Hill DJ; Potter JM; Cullen DR; Milner RD
J Clin Endocrinol Metab; 1981 Aug; 53(2):439-42. PubMed ID: 7019232
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.
Wiedemann E; Schwartz E; Frantz AG
J Clin Endocrinol Metab; 1976 May; 42(5):942-52. PubMed ID: 178687
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism.
Clemmons DR; Underwood LE; Ridgway EC; Kliman B; Van Wyk JJ
J Clin Endocrinol Metab; 1981 Apr; 52(4):731-5. PubMed ID: 7193685
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid effects on somatomedins and somatomedin inhibitors.
Unterman TG; Phillips LS
J Clin Endocrinol Metab; 1985 Oct; 61(4):618-26. PubMed ID: 4031007
[TBL] [Abstract][Full Text] [Related]
5. Somatomedin inhibitor in uremia.
Phillips LS; Fusco AC; Unterman TG; del Greco F
J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels.
Yamashita S; Melmed S
Endocrinology; 1986 Jan; 118(1):176-82. PubMed ID: 3079701
[TBL] [Abstract][Full Text] [Related]
7. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
[TBL] [Abstract][Full Text] [Related]
8. Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin.
Minuto F; Underwood LE; Grimaldi P; Furlanetto RW; Van Wyk JJ; Giordano G
J Clin Endocrinol Metab; 1981 Mar; 52(3):399-403. PubMed ID: 7193217
[TBL] [Abstract][Full Text] [Related]
9. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
10. Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin.
Ceda GP; Hoffman AR; Silverberg GD; Wilson DM; Rosenfeld RG
J Clin Endocrinol Metab; 1985 Jun; 60(6):1204-9. PubMed ID: 3889029
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone secretion in empty sella syndrome.
Brismar K
J Endocrinol Invest; 1982; 5(6):417-22. PubMed ID: 6763056
[TBL] [Abstract][Full Text] [Related]
12. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome.
Griep EN; Boersma JW; de Kloet ER
J Rheumatol; 1994 Nov; 21(11):2125-30. PubMed ID: 7869322
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
[TBL] [Abstract][Full Text] [Related]
14. Nutrition and somatomedin. II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats.
Phillips LS; Young HS
Diabetes; 1976 Jun; 25(6):516-27. PubMed ID: 132381
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man.
Barbetti F; Crescenti C; Negri M; Leonetti F; Grossi A; Tamburrano G
J Clin Endocrinol Metab; 1990 May; 70(5):1371-4. PubMed ID: 2110574
[TBL] [Abstract][Full Text] [Related]
16. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
[TBL] [Abstract][Full Text] [Related]
17. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
18. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia-induced prolactin release.
May PB; Burrow GN; Kayne RD; Donabedian RK
Arch Intern Med; 1978 Jun; 138(6):918-20. PubMed ID: 565624
[TBL] [Abstract][Full Text] [Related]
20. Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth.
Gluckman PD; Holdaway IM
Clin Endocrinol (Oxf); 1976 Sep; 5(5):545-9. PubMed ID: 991434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
